Rapid COVID-19 testing now in the Ontario workplace

23 March 2021

The Provincial Government recently announced that it is relaxing the regulations around the use of COVID-19 Rapid Antigen Tests ("RAT") to make it easier for businesses to test for COVID-19 in the workplace. Employees who want to self-swab for a rapid antigen point-of-care test in the workplace offered by their employer will now be able to do so.

Ontario initially launched the Provincial Antigen Screening Program as a pilot in November 2020, to deploy RAT to essential workplaces and sectors, to quickly identify and help stop the spread of COVID-19. Now the province has expanded rapid testing and made it easier to administer in the workplace. The Laboratory and Specimen Collection Centre Licensing Act, R.S.O. 1990, c. L.1 and its Laboratories Regulations R.R.O. 1990, Reg. 68 have been amended to exempt "COVID-19 point-of-care Testing", like RATs, from the habitual regulatory requirements for the collection and testing of specimens taken from the human body.

As a result of these statutory changes, there are fewer limitations on employers wanting to implement such testing measures in the workplace. RAT do not require administration by a health-care professional, can be administered at virtually any location/workplace, and will typically provide an immediate test result within 15-20 minutes.

While RAT will likely assist employers to ensure the health and safety of their workplace pursuant to occupational health and safety obligations, it is a screening tool only. RAT is not a diagnostic tool for COVID-19 infection in symptomatic individuals, or individuals with known contact with a positive COVID-19 case. Therefore, current workplace screening protocols need to remain in place.

Health Canada has suggested that RAT are useful for monitoring asymptomatic people in high-risk settings, repeated testing of workers in remote work areas to prevent the introduction or minimize the spread of infection, repeated testing of inmates and workers in correctional facilities, and regular testing of workers in high-risk settings such as long-term care facilities, construction sites, educational facilities and large food processing facilities.

A positive RAT result will require a follow-up polymerase chain reaction (nasopharyngeal swab) test.

There are a number of important legal issues that can arise from the use of RAT . Employers who are considering implementing RATs as part of their workplace screening protocols, should review provincial guidance and ensure that supervising staff have followed the Ontario Ministry of Health's training.

The use of RAT should be conducted on a voluntary basis and the personal health information obtained through RATs should not be collected, recorded, stored, used or disclosed without the employee's consent, except as required by the Health Protection and Promotion Act, R.S.O. 1990, c. H.7. Employers should also consider a number of practical points such as who will supervise the administration of RATs in their workplace, how the employee's personal health information will be secured, and whether there is clear employer guidance on the use of tests and test results as part of its screening protocol.

Before implementing Rapid Antigen COVID-19 Tests, Employers should contact a member of Gowling WLG's Employment, Labour & Equalities Group to discuss risk mitigation in their workplace, along with the associated employment and privacy considerations.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.